Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity
Tools
Sheldrake, Helen M., Travica, Sandra, Johansson, Inger, Loadman, Paul M., Sutherland, Mark, Elsalem, Lina, Illingworth, Nicola, Cresswell, Alexander J., Reuillon, Tristan, Shnyder, Steven D., Mkrtchian, Souren, Searcey, Mark, Ingelman-Sundberg, Magnus, Patterson, Laurence H. and Pors, Klaus (2013) Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity. Journal of Medicinal Chemistry, 56 (15). pp. 6273-6277. ISSN 0022-2623
Full text not available from this repository. (Request a copy)Item Type: | Article |
---|---|
Faculty \ School: | Faculty of Science > School of Pharmacy |
Depositing User: | Pure Connector |
Date Deposited: | 20 Aug 2013 05:29 |
Last Modified: | 09 Jul 2020 23:43 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/43143 |
DOI: | 10.1021/jm4000209 |
Actions (login required)
![]() |
View Item |